Board to approve Q2 and half-year results on November 4, 2026
KIMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.9 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board will meet on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and six months ended September 30, 2026. Trading in the company's shares is closed from October 1 until 48 hours after the results are published.
The filing is procedural and contains no results figures or new financial guidance, so there is no clear stock signal until the results are announced.